Pharma, Healthcare & Lifesciences - Extremely Complex Regulatory Landscape - Key Learnings From Expert GCs

Update: 2024-09-10 10:30 GMT
story

13th Annual Legal Era India Conclave 2024 | Day 3: Panel On Pharma, Healthcare & Lifesciences Catch the replay of the engaging panel discussion from Day 3 of the 13th Annual Legal Era India Conclave 2024, where industry leaders discussed the complex regulatory landscape within the Pharma, Healthcare, and Lifesciences sectors. Key Highlights: Navigating the highly regulated pharma...


Full View


13th Annual Legal Era India Conclave 2024 | Day 3: Panel On Pharma, Healthcare & Lifesciences

Catch the replay of the engaging panel discussion from Day 3 of the 13th Annual Legal Era India Conclave 2024, where industry leaders discussed the complex regulatory landscape within the Pharma, Healthcare, and Lifesciences sectors.

Key Highlights:

  • Navigating the highly regulated pharma and healthcare industries
  • Understanding the evolving regulatory challenges and compliance issues
  • Insights from leading General Counsels on managing legal complexities in this space

Featured Panelists:

  • Kaizad Adi Hazari, Group General Counsel, The Chatterjee Group (TCG)
  • Anumeha Soni, Senior Director, Thermo Fisher Scientific
  • Sormistha Ghosh, Group General Counsel and Chief Risk Officer, Strides Pharma

Moderator:

This panel highlighted the intricacies of legal and regulatory challenges within the Pharma and Healthcare industries, offering valuable takeaways from expert General Counsels in the field.

Session Partner: Cyril Amarchand Mangaldas

Don't miss the replay for insights into how regulatory frameworks are evolving and what it takes to stay ahead in this dynamic sector.

#13thAnnualLegalEra #LegalEraConclave2024 #PharmaHealthcareLifesciences #RegulatoryChallenges #HealthcareLaw #PharmaLaw #Compliance #GeneralCounsel #LegalInsights #KaizadAdiHazari #TheChatterjeeGroup #AnumehaSoni #ThermoFisherScientific #SormisthaGhosh #StridesPharma #AshwinSapra #CyrilAmarchandMangaldas #LegalProfessionals #PharmaIndustry #HealthcareIndustry #Lifesciences #RegulatoryFramework #LegalCompliance #LegalComplexities #PharmaCompliance #HealthcareRegulations #LegalTrends #IndustryLeaders #Replay #LegalDiscussion

Tags:    

Similar News

AI & IP

Cross Border Investments & FDI